Episode Details

Back to Episodes
Helping Eye Cells Take Out Their Trash May Protect the Optic Nerve From Glaucoma

Helping Eye Cells Take Out Their Trash May Protect the Optic Nerve From Glaucoma

Published 2 months, 2 weeks ago
Description

This audio article is from VisualFieldTest.com.

Read the full article here: https://visualfieldtest.com/en/helping-eye-cells-take-out-their-trash-may-protect-the-optic-nerve-from-glaucoma

Test your visual field online: https://visualfieldtest.com

Support the show so new episodes keep coming: https://www.buzzsprout.com/2563091/support

Excerpt:

Helping Eye Cells Take Out Their Trash May Protect the Optic Nerve From Glaucoma Evidence review current to September 2, 2026 Introduction Lowering eye pressure remains the most proven way to slow glaucoma. Yet some people continue to lose retinal nerve tissue and vision even when their eye pressure is considered controlled. This is especially relevant in normal-tension glaucoma, but it can also occur in ordinary open-angle glaucoma after pressure-lowering treatment. One possible explanation is that pressure is only the initial stress. The lasting damage may also depend on whether retinal ganglion cells can maintain their mitochondria, transport cellular cargo along their axons, control oxidative stress, and remove damaged cell parts. A study published in 2026 provides some of the clearest evidence so far for this idea. The investigators used Torin 2, a powerful laboratory inhibitor of the mechanistic target of rapamycin pathway, to increase autophagy and mitophagy—the processes cells use to recycle damaged proteins and mitochondria. In mouse glaucoma models, Torin 2 reduced the buildup of abnormal mitochondria and preserved retinal ganglion cells, optic nerve axons, and electrical retinal responses. It also increased survival of retinal ganglion cells in human retinal tissue maintained in the laboratory. () The findings are important, but they do not establish Torin 2 as a treatment. The compound was given by injection into the mouse eye at a research concentration, it has broad kinase effects, visual behavior was not tested, and the study did not directly measure mitochondrial respiration or energy production. The most useful interpretation is narrower: > Glaucoma may involve a failure of mitochondrial quality control, and selectively restoring mitochondrial clearance could become a form of pressure-independent neuroprotection. What the Recent Torin 2 Study Actually Showed The experimental design The study used several complementary approaches: A glucocorticoid-induced ocular hypertension mouse model, in which eye pressure was elevated for 10 weeks. A mutant myocilin mouse model, representing a form of inherited open-angle glaucoma. Mt-Keima reporter mice, which allow researchers to measure mitophagy flux—the delivery of mitochondria to acidic lysosomes for degradation. Retinal ganglion-cell-specific deletion of autophagy-related gene 5, testing what happens when autophagy is removed directly from retinal ganglion cells. Human retinal explants, cultured outside the body under conditions that normally cause progressive retinal ganglion-cell death. () The investigators found that chronic eye-pressure elevation caused abnormal mitochondrial accumulation, oxidative DNA damage, and reduced mitophagy flux. Importantly, the mitophagy defect appeared before substantial retinal ganglion-cell loss, suggesting that impaired clearance may be an early event rather than merely a consequence of dying neurons. () Reported effects of Torin 2 For the full table, please open this article on visualfieldtest.com. The pattern electroretinogram result can be expressed in two ways: Compared with injured vehicle-treated eyes, the mean response was approximately 83% higher: \[ (31.82 - 17.36) / 17.36 \approx 83\% \] Relative to the entire deficit between injured eyes and non-hypertensive controls, Torin 2 clos

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us